Completed
A Study to Evaluate 3 Dose Schedules of Daratumumab in Participants With Smoldering Multiple Myeloma
NCT02316106
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- Little Rock, Arkansas, United States
- Jacksonville, Florida, United States
- West Palm Beach, Florida, United States
- Atlanta, Georgia, United States